See also this year's filing and all EDGAR filings for this company.
PDF Report 0001082554_2022_United_Therapeutics_Corp.pdf
Logs
| info | NetIncome node detected by tax heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'} |
Graph
Absolute values for 0001082554, United Therapeutics Corp
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 2,323,600,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 780,900,000 |
| 3 | remainder_Assets | 2,064,600,000 |
| 4 | LiabilitiesCurrent | 305,400,000 |
| 5 | LiabilitiesNoncurrent | 104,800,000 |
| 6 | remainder_Liabilities | 800,000,000 |
| 7 | CostOfGoodsAndServicesSold | 118,867,484 |
| 8 | SellingGeneralAndAdministrativeExpense | 0 |
| 9 | ResearchAndDevelopmentExpense | 474,452,135 |
| 10 | remainder_Expenses | 576,500,476 |
| 11 | remainder_Revenues | 1,835,593,083 |
| 12 | remainder_NetIncome | 40,193,011 |
| 13 | remainder_ComprehensiveNetIncome | -3,157,603 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 5,169,100,000 |
| 1 | Liabilities | 1,210,200,000 |
| 2 | Expenses | 1,169,820,095 |
| 3 | Revenues | 1,835,593,083 |
| 4 | StockholdersEquity | 3,958,900,000 |
| 5 | NetIncome | 705,965,999 |
| 6 | ComprehensiveNetIncome | 704,387,198 |
| 7 | BaseVar | 4,714,031,896 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.93 |
| 9 | EconomicCapitalRatio | 3.64 |
Edgar->Model Mapping
Feature Distribution
Change over Time
